Ghatkopar (East), Mumbai)
Home >Dermatology > Narrowband UVB (NB-UVB) Phototherapy
Narrowband UVB (NB-UVB) Phototherapy in Mumbai
Precision Ultraviolet Light Therapy for Psoriasis, Vitiligo, and Inflammatory Skin Conditions
Narrowband UVB phototherapy delivers a precisely controlled wavelength of ultraviolet B light - 311 to 313 nanometres - that suppresses the abnormal immune activity driving inflammatory skin diseases, without the broader UV spectrum that causes unnecessary skin damage. Narrowband UVB phototherapy in Mumbai at Shree Hospitals is administered in a dedicated phototherapy unit with calibrated cabinets, computerised dose tracking, and dermatologist-supervised protocols that ensure every session delivers the therapeutic dose required - not more, not less. It remains one of the safest and most effective treatments for psoriasis, vitiligo, and a range of other photoresponsive skin conditions.
Don't Ignore Skin Problems. Get Expert Dermatology Care Today.
Quick facts
Type of Procedure: Whole-body or targeted narrowband UVB light exposure in a phototherapy cabinet
Duration of Each Session: 30 seconds to 10 minutes depending on cumulative dose and skin response
Type of Anaesthesia: No anaesthesia required
Recovery Duration: No downtime; patients return to normal activity immediately after each session
Key Benefit: Safe, effective UV immunosuppression for psoriasis, vitiligo, and atopic dermatitis - without systemic drug side effects
Type of Insurance: Covered under major health insurance policies for indicated dermatological conditions
What Is Narrowband UVB (NB-UVB) Phototherapy?
Ultraviolet light has been used therapeutically in dermatology for over a century. The evolution from broadband UVB and PUVA to NB-UVB treatment for psoriasis Mumbai India represents one of the most important refinements in phototherapy - isolating the most therapeutically active wavelength while eliminating the broader UV spectrum responsible for erythema, burning, and long-term photocarcinogenesis risk.
Narrowband UVB at 311 to 313 nm penetrates the epidermis and superficial dermis where it exerts its therapeutic effect - inducing T-cell apoptosis, suppressing dendritic cell maturation, increasing regulatory T-cell activity, and reducing the production of pro-inflammatory cytokines including IL-17 and IL-23 that drive psoriasis and other inflammatory skin conditions. This immune modulation occurs locally in the skin without significant systemic immunosuppression - making NB-UVB an appropriate treatment during pregnancy, in children, and in patients with comorbidities contraindicating systemic drugs.
UVB phototherapy for vitiligo works through a different mechanism - stimulating melanocyte proliferation and migration from follicular reservoirs into depigmented skin. Repigmentation typically begins as perifollicular dots that expand and coalesce over months of treatment. Response is best on sun-exposed sites - face, neck, and arms - and in patients with disease duration under 2 years. At Shree Hospitals, narrowband UVB light therapy Mumbai protocols are individualised - starting dose determined by minimum erythema dose testing or skin phototype, with incremental dose escalation based on documented skin response at each session.
When Should You Consider NB-UVB Phototherapy?
Narrowband UVB is indicated for:
- Plaque psoriasis - moderate extent not controlled by topicals
- Guttate psoriasis - particularly post-streptococcal
- Active spreading vitiligo - face, trunk, and proximal limbs
- Atopic dermatitis in adults and older children
- Mycosis fungoides - early-stage cutaneous T-cell lymphoma
- Prurigo nodularis and chronic pruritus of dermatological origin
- Polymorphic light eruption - paradoxical desensitisation protocol
- Pityriasis lichenoides chronica and parapsoriasis
Is This Treatment Right for You?
NB-UVB phototherapy is appropriate when:
- Disease is moderate extent, making topical treatment impractical
- Systemic drugs are contraindicated - pregnancy, liver disease, renal impairment
- Patient can attend 2 to 3 sessions per week for 12 to 24 weeks
- No photosensitising medications or photodermatosis diagnosis
- Targeted phototherapy skin treatment is feasible for limited disease sites
- Skin phototype and minimum erythema dose have been assessed pre-treatment
Why Choose NB-UVB Over Topical or Systemic Treatment?
- No systemic drug toxicity - no liver monitoring, no renal function tests
- Safe in pregnancy - preferred over methotrexate, acitretin, and most biologics
- UVB phototherapy for vitiligo stimulates repigmentation no cream can achieve
- Clears extensive disease that would require impractical quantities of topical treatment
- Phototherapy unit dermatology Mumbai at Shree Hospitals tracks cumulative dose - lifetime safety limit is actively managed
- Effective maintenance - monthly sessions sustain remission after initial clearance course
Narrowband UVB phototherapy achieves psoriasis clearance rates comparable to conventional systemic therapy - without liver toxicity, renal toxicity, or systemic immunosuppression.
For patients who cannot or prefer not to take systemic drugs, phototherapy is not a compromise. It is a first-class treatment.
24×7 Emergency Care
Our Approach To Narrowband UVB (NB-UVB) Phototherapy
Phototherapy is frequently underestimated as a passive, routine procedure. It is not. Incorrect starting dose causes painful burns that set treatment back weeks. Inadequate dose escalation produces no benefit. Exceeding cumulative lifetime limits increases skin cancer risk. At Shree Hospitals, narrowband UVB phototherapy in Mumbai is a physician-supervised programme - not a nurse-run service operating without dermatologist input. Every protocol is written by the dermatologist, every dose escalation is tracked, and every adverse reaction is reviewed before the next session.
24×7 Emergency Care
Minimum Erythema Dose Testing and Starting Dose
Before the first treatment session, minimum erythema dose is determined - small areas of skin on the inner forearm are exposed to increasing UV doses and read at 24 hours to identify the lowest dose producing just perceptible erythema. This individual biological response calibrates the starting treatment dose precisely, avoiding under-dosing that produces no therapeutic effect and over-dosing that produces painful burning. NB-UVB treatment for psoriasis Mumbai India starting doses based on MED testing are more accurate than skin phototype-based estimates alone.
Dose Escalation Protocol
After each session, the dermatologist or trained phototherapy nurse reviews the patient's skin response - no erythema, faint erythema, or significant erythema. The next session dose is escalated by 10 to 20% if no or minimal erythema is present. Dose escalation is withheld if significant erythema persists from the previous session. This stepwise escalation - guided by clinical skin response - builds to the therapeutic dose range of 70 to 80% of MED over the first few weeks. Computerised dose records track every session - cumulative dose, session dose, and erythema response.
Targeted Phototherapy for Limited Disease
For patients with psoriasis or vitiligo affecting limited body surface areas - hands, scalp, or isolated plaques - targeted phototherapy using a handheld or focused UVB device delivers high-dose UV precisely to the affected area while sparing surrounding normal skin. This avoids the cumulative UV exposure of whole-body cabinet treatment and is particularly appropriate for children and patients with limited but treatment-resistant lesions. Targeted phototherapy skin treatment sessions are shorter and better tolerated than whole-body cabinet sessions.
Cumulative Dose Tracking and Session Limits
The safety of NB-UVB phototherapy depends on lifelong cumulative dose management. Each session's dose in mJ/cm² is recorded in the patient's phototherapy log. Total cumulative dose across all treatment courses is tracked. The dermatologist reviews cumulative dose at each course of treatment - patients approaching 1000 sessions or high cumulative dose thresholds are counselled on the modestly increased long-term skin cancer risk and alternative treatment options. Narrowband UVB light therapy Mumbai at Shree Hospitals does not simply restart courses indefinitely - cumulative dose management is a formal part of the programme.
Top Dermatology Specialists In Mumbai
Every hair restoration and scalp procedure at Shree Hospitals is performed by senior consultant dermatologists with subspecialty training in trichology, hair loss diagnosis, and scalp procedure techniques. Now at Shree Hospitals, Mumbai.
24×7 Emergency Care
Dr. Yogesh Kalyanpad
Consultant Dermatologist
Dermatology Treatments At Shree Hospitals
Narrowband UVB phototherapy is one component of a comprehensive dermatology programme at Shree Hospitals - covering both medical and procedural treatments for inflammatory, pigmentary, and aesthetic skin conditions.
Phototherapy & Biologic Therapy
Phototherapy and biologic therapy are advanced treatments for chronic skin conditions such as psoriasis, vitiligo, and eczema. They help control inflammation, improve skin healing, and reduce disease flare-ups when conventional treatments are insufficient.
Laser Dermatology & Skin Rejuvenation
Laser treatments improve skin texture, pigmentation, acne scars, fine lines, unwanted hair, and vascular lesions using precise energy-based technology with minimal downtime.
Step By Step Process Of Nb Uvb Phototherapy
Step 1: Phototherapy Consultation and Indication Confirmation
The dermatologist reviews the diagnosis, disease extent and severity, prior treatment history, current medications, and any photosensitivity history. Photosensitising medications - tetracyclines, thiazides, quinolones, amiodarone - are identified and managed before phototherapy begins. Absolute contraindications - photodermatoses including lupus, xeroderma pigmentosum, and Gorlin syndrome - are excluded. The phototherapy protocol is explained including frequency, expected course duration, anticipated response timeline, and possible side effects.
Step 2: Minimum Erythema Dose Testing
A test dose session is performed before the first treatment - six to eight small areas of unexposed skin on the inner forearm receive increasing UV doses from the phototherapy device. Results are read at 24 hours by the dermatologist - the dose producing the lowest visible erythema is the MED. The starting treatment dose is set at 50 to 70% of the MED. This individual calibration step takes one visit and significantly improves the safety and efficacy of the treatment course compared to phototype-based starting dose estimation.
Step 3: First Treatment Sessions and Observation
The first few treatment sessions are administered at the MED-based starting dose with the patient standing in the phototherapy cabinet with eyes protected by UV-blocking goggles and genitalia shielded. Skin not requiring treatment - unaffected areas in vitiligo - is covered with clothing or sunblock. Session duration is brief - often under 60 seconds at initial doses. The patient is instructed to call the phototherapy nurse immediately if they experience burning or pain during or after the session. Response to the first few sessions guides dose escalation pace.
Step 4: Escalating Dose Sessions
Sessions continue 2 to 3 times per week on non-consecutive days - allowing skin to recover between exposures. Dose is escalated by 10 to 20% per session where erythema response is within the target range. Patients with minimal erythema tolerance - particularly those on medications affecting UV sensitivity - have slower escalation schedules. By weeks 4 to 6, most patients reach the therapeutic dose range. For UVB phototherapy for vitiligo, the dose targets are somewhat lower than psoriasis - just below the erythema threshold to stimulate melanocytes without damaging them.
Step 5: Mid-Course Response Assessment
At weeks 8 and 16, the dermatologist conducts a formal response assessment - clinical examination, photography comparison, and PASI or VASI scoring. Psoriasis patients achieving significant clearance continue to completion. Vitiligo patients showing perifollicular repigmentation are encouraged to continue - repigmentation response is slower and requires patience. Patients not responding after 24 sessions are assessed for protocol non-adherence, photosensitivity, or fundamental non-response before the course is discontinued. Phototherapy unit dermatology Mumbai response rates are documented and tracked across the programme.
Step 6: Course Completion and Maintenance
After achieving clearance or maximum response, the course is tapered - session frequency reduced from 3 to 2 to 1 per week before stopping. Maintenance sessions - once weekly or fortnightly - may be offered to patients who relapse rapidly off treatment. Cumulative dose is recorded and the patient's phototherapy log updated. If a further course is needed in the future, the cumulative total from all previous courses informs the decision. Patients with high cumulative doses are counselled on annual skin examination for photodamage and early skin malignancy.
Patient Questions About Narrowband UVB (NB-UVB) Phototherapy
What are the benefits of narrowband UVB over broadband phototherapy?
Narrowband UVB (NB-UVB) delivers a specific wavelength of ultraviolet light that is more effective for treating psoriasis, vitiligo, and eczema while exposing the skin to less unnecessary UV radiation. This improves treatment outcomes and reduces the risk of unwanted side effects.
What are the side effects and long-term risks of NB-UVB?
NB-UVB therapy is generally safe but may cause temporary redness, itching, dryness, or mild sunburn-like reactions. With appropriate dosing and regular monitoring, the long-term risk of skin damage is low compared with older broadband phototherapy treatments.
What should you ask during your phototherapy consultation?
Ask whether phototherapy is suitable for your skin condition, how many sessions you may need, expected results, possible side effects, precautions before and after treatment, and whether you should continue your current medications during therapy.
How many sessions will I need before seeing results?
Most patients begin to notice improvement after 8 to 12 phototherapy sessions, although the exact number varies depending on the condition, its severity, and individual response. Completing the full treatment course and attending sessions regularly provides the best long-term results.
Evidence-Based Case Studies by Our Specialists
Would Recommend Us
Moderate plaque psoriasis - 15% BSA involvement on trunk and limbs. Unable to take methotrexate due to planned pregnancy. Narrowband UVB phototherapy in Mumbai initiated after MED testing. PASI score of 14 at baseline. Completed 32 sessions over 11 weeks. PASI score 2 at course completion - PASI 86 response. Maintained clearance with monthly maintenance sessions through early pregnancy under dermatologist supervision
Mrs. Sulabha, M
Child with rapidly spreading facial vitiligo - bilateral periocular and perioral depigmentation over 6 months. UVB phototherapy for vitiligo - targeted NB-UVB initiated three times weekly. Perifollicular repigmentation noted at 10 weeks. Significant coalescence of repigmentation at 20 weeks - 65% facial repigmentation achieved at course completion. Parents and child highly satisfied with cosmetically significant improvement.
Mr. Arjun, L
Severe adult atopic dermatitis with widespread involvement and intractable pruritus not controlled with topical steroids and tacrolimus. NB-UVB treatment for psoriasis Mumbai India unit used for atopic dermatitis - EASI score 28 at baseline. After 24 sessions, EASI score 8 - 71% improvement. Sleep quality improved dramatically. Continues on maintenance phototherapy monthly to sustain response without systemic immunosuppression.
Mr. Vikram, D
Patient
Resources
Schedule
consultation
Billing &
Payments
Hospital
Facilities
24×7 Emergency Care
1800-268-4000
Follow Us
Shree
Hospitals
Shree
Hospitals
